These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21466449)

  • 41. Targeting the endocannabinoid system in treating brain disorders.
    Bahr BA; Karanian DA; Makanji SS; Makriyannis A
    Expert Opin Investig Drugs; 2006 Apr; 15(4):351-65. PubMed ID: 16548785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system.
    Lenman A; Fowler CJ
    Br J Pharmacol; 2007 Aug; 151(8):1343-51. PubMed ID: 17592505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacotherapeutic modulation of the endocannabinoid signalling system in psychiatric disorders: drug-discovery strategies.
    Janero DR; Vadivel SK; Makriyannis A
    Int Rev Psychiatry; 2009 Apr; 21(2):122-33. PubMed ID: 19367506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
    Nozaki C; Markert A; Zimmer A
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Architecture of cannabinoid signaling in mouse retina.
    Hu SS; Arnold A; Hutchens JM; Radicke J; Cravatt BF; Wager-Miller J; Mackie K; Straiker A
    J Comp Neurol; 2010 Sep; 518(18):3848-66. PubMed ID: 20653038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells.
    Muccioli GG; Xu C; Odah E; Cudaback E; Cisneros JA; Lambert DM; López Rodríguez ML; Bajjalieh S; Stella N
    J Neurosci; 2007 Mar; 27(11):2883-9. PubMed ID: 17360910
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
    Connell K; Bolton N; Olsen D; Piomelli D; Hohmann AG
    Neurosci Lett; 2006 Apr; 397(3):180-4. PubMed ID: 16378681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measuring endocannabinoid hydrolysis: refining our tools and understanding.
    Marrs W; Stella N
    AAPS J; 2009 Jun; 11(2):307-11. PubMed ID: 19424807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the cannabinoid system for pain relief?
    Chiou LC; Hu SS; Ho YC
    Acta Anaesthesiol Taiwan; 2013 Dec; 51(4):161-70. PubMed ID: 24529672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.
    Egertová M; Cravatt BF; Elphick MR
    Neuroscience; 2003; 119(2):481-96. PubMed ID: 12770562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
    Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
    Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
    Ueda N; Tsuboi K; Uyama T; Ohnishi T
    Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatty acid amide hydrolase: a potential target for next generation therapeutics.
    Maccarrone M
    Curr Pharm Des; 2006; 12(6):759-72. PubMed ID: 16472164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB₁ receptor ligand.
    Ligresti A; Villano R; Allarà M; Ujváry I; Di Marzo V
    Pharmacol Res; 2012 Aug; 66(2):163-9. PubMed ID: 22525682
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.
    Della Pietra A; Savinainen J; Giniatullin R
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol.
    Dinh TP; Kathuria S; Piomelli D
    Mol Pharmacol; 2004 Nov; 66(5):1260-4. PubMed ID: 15272052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.